The company offers an array of outsourcing options including high-throughput DNA sequencing, bioinformatics, vector Development Services, peptides synthesis and antibodies production. By using the patented technology MutaGen™, MilleGen has genetically engineered recombinant antibodies library in which selecting antibodies from the library for the specific targets provided by customers is also available.